Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients

Clinical trial NCT07631611 · COMPLETED

Trial details

NCT number: NCT07631611
Sponsor: Wenlong Zhong, MD
Status: COMPLETED
Study type: OBSERVATIONAL

Solid Tumors Metastatic Cancer to Liver Metastatic Cancer to the Bone Metastatic Cancer to the Lung Brain Metastasis Metastatic Cancers Immune Checkpoint Inhibitors Tumor Immune Microenvironment

Start date: 2016-01-01
Primary completion: 2026-05-20
Enrollment: 938

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.